CIK 0001294133 · Accelerated filer<br>Smaller reporting company
Inogen Inc
Sign in to watch- Ticker
- INGN
- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 805-562-0500
- Business address
- 500 CUMMINGS CENTER, SUITE 2800, BEVERLY, MA, 01915
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-01 | Smith Kevin P. EVP, Bus Dev, GC & Sec | Option exercise · Restricted Stock Unit 10b5-1 | −18,135 | 36,271 | ||
| 2025-09-01 | Smith Kevin Raymond Merrill CEO and President | Grant or award 10b5-1 | +1,500 | $7.99 | $12K | 71,774 |
| 2025-09-01 | Bourque Michael J. EVP, CFO & Treasurer | Grant or award 10b5-1 | +1,500 | $7.99 | $12K | 49,146 |
| 2025-05-14 | Boehnlein Glenn S Director | Grant or award | +30,612 | 76,885 | ||
| 2025-05-14 | Rider Heather D. Director | Grant or award | +30,612 | 88,201 | ||
| 2025-05-14 | Sahney Mira Kirti Director | Grant or award | +30,612 | 39,724 | ||
| 2025-05-14 | Mora Elizabeth Director | Grant or award | +30,612 | 79,180 | ||
| 2025-05-14 | Ladone Mary Kay Director | Grant or award | +30,612 | 76,885 | ||
| 2025-05-14 | King Kevin M Director | Grant or award | +30,612 | 76,885 | ||
| 2025-03-03 | Bourque Michael J. EVP, CFO & Treasurer | Purchase 10b5-1 | +3,000 | $8.32 | $25K | 47,646 |
| 2025-03-03 | Smith Kevin Raymond Merrill CEO and President | Purchase 10b5-1 | +11,709 | $8.56 | $100K | 70,274 |
| 2025-03-01 | Smith Kevin P. EVP, Bus Dev, GC & Sec | Grant or award 10b5-1 | +1,186 | $8.33 | $10K | 1,186 |
| 2025-03-01 | Bourque Michael J. EVP, CFO & Treasurer | Grant or award 10b5-1 | +600 | $8.33 | $5K | 600 |
| 2025-03-01 | Bourque Michael J. EVP, CFO & Treasurer | Option exercise 10b5-1 | +25,000 | 25,600 | ||
| 2025-03-01 | Bourque Michael J. EVP, CFO & Treasurer | Shares withheld for taxes 10b5-1 | −9,838 | $8.33 | $82K | 15,762 |
| 2025-03-01 | Bourque Michael J. EVP, CFO & Treasurer | Grant or award 10b5-1 | +47,625 | 63,387 | ||
| 2025-03-01 | Bourque Michael J. EVP, CFO & Treasurer | Shares withheld for taxes 10b5-1 | −18,741 | $8.33 | $156K | 44,646 |
| 2025-03-01 | Bourque Michael J. EVP, CFO & Treasurer | Option exercise · Restricted Stock Unit 10b5-1 | −25,000 | 50,000 | ||
| 2025-03-01 | Smith Kevin Raymond Merrill CEO and President | Grant or award 10b5-1 | +1,500 | $8.33 | $12K | 16,054 |
| 2025-03-01 | Smith Kevin Raymond Merrill CEO and President | Option exercise 10b5-1 | +28,333 | 44,387 |
Page 5 of 15 · 281 trades